Inflammation in cerebral ischemia reperfusion improved by avanafil via nod-like receptor protein-3 inflammasome: an experimental study in rats

References

• Nagai M, Granger DN. Chapter 19 - inflammatory mechanisms in ischemic cerebrovascular disease. In: Minagar A, editor. Neuroinflammation. Second ed. LA, USA: Academic Press; 2018. p. 379–411.
   Google Scholar
• Girotra T, Lekoubou A, Bishu KG, Ovbiagele B. A contemporary and comprehensive analysis of the costs of stroke in the United States. J Neurol Sci. 2020;410:116643. doi:10.1016/j.jns.2019.116643.
   PubMed Web of Science ®Google Scholar
• George MG, Tong X, Bowman BA. Prevalence of cardiovascular risk factors and strokes in younger adults. JAMA Neurol. 2017;74(6):695–703. doi:10.1001/jamaneurol.2017.0020.
   PubMed Web of Science ®Google Scholar
• Chen W, Li D. Reactive oxygen species (ROS)-responsive nanomedicine for solving ischemia-reperfusion injury. Front Chem. 2020;8:732. doi:10.3389/fchem.2020.00732.
   PubMed Web of Science ®Google Scholar
• Yilmaz EPT, Un H, Gundogdu B, Polat E, Askin S, Topdagi YE, Halici Z. Protective effect of lycopene against reperfusion injury in rats with ovarian torsion: a biochemical and histopathological evaluation. J Lab Physicians. 2020;12(1):32–37. doi:10.1055/s-0040-1715553.
   PubMedGoogle Scholar
• Bayir Y, Cadirci E, Polat B, Kilic Baygutalp N, Albayrak A, Karakus E, Un H, Keles MS, Kocak Ozgeris FB, Toktay E, et al. Aliskiren – a promising strategy for ovarian ischemia/reperfusion injury protection in rats via RAAS. Gynecol Endocrinol. 2016;32(8):675–83. doi:10.3109/09513590.2016.1153055.
   PubMed Web of Science ®Google Scholar
• Celik M, Aksoy AN, Aksoy H, Aksoy Y, Halici Z. Sildenafil reduces ischemia-reperfusion injury in rat ovary: biochemical and histopathological evaluation. Gynecol Obstet Invest. 2014;78(3):162–67. doi:10.1159/000363747.
   PubMed Web of Science ®Google Scholar
• Wallis RM, Corbin JD, Francis SH, Ellis P. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro. Am J Cardiol. 1999;83(5a):3c–12c. doi:10.1016/S0002-9149(99)00042-9.
   PubMed Web of Science ®Google Scholar
• Maurice DH, Ke H, Ahmad F, Wang Y, Chung J, Manganiello VC. Advances in targeting cyclic nucleotide phosphodiesterases. Nat Rev Drug Discov. 2014;13(4):290–314. doi:10.1038/nrd4228.
   PubMed Web of Science ®Google Scholar
• Das A, Xi L, Kukreja RC. Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3β*. J Biol Chem. 2008;283(43):29572–85. doi:10.1074/jbc.M801547200.
   PubMed Web of Science ®Google Scholar
• Das A, Durrant D, Salloum FN, Xi L, Kukreja RC. PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer. Pharmacology & Therapeutics. 2015;147:12–21. doi:10.1016/j.pharmthera.2014.10.003.
   PubMed Web of Science ®Google Scholar
• Kukreja RC, Salloum FN, Das A. Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection. J Am Coll Cardiol. 2012;59(22):1921–27. doi:10.1016/j.jacc.2011.09.086.
   PubMed Web of Science ®Google Scholar
• Corinaldesi C, Luigi L, Lenzi A, Crescioli C. Phosphodiesterase type 5 inhibitors: back and forward from cardiac indications. J Endocrinol Invest. 2015;39(2):143–51. doi:10.1007/s40618-015-0340-5.
   PubMed Web of Science ®Google Scholar
• Ameli M, Hashemi MS, Moghimian M, Shokoohi M. Protective effect of tadalafil and verapamil on testicular function and oxidative stress after torsion/detorsion in adult male rat. Andrologia. 2018;50(8):e13068. doi:10.1111/and.13068.
   PubMed Web of Science ®Google Scholar
• Ali BH, Al Za’abi M, Adham SA, Al Suleimani Y, Karaca T, Manoj P, Al Kalbani J, Yasin J, Nemmar A. The effect of sildenafil on rats with adenine—induced chronic kidney disease. Biomed Pharmacother. 2018;108:391–402. doi:10.1016/j.biopha.2018.09.061.
   PubMed Web of Science ®Google Scholar
• Sertkaya Z, Koca O, Ozturk M, Akyuz M, Gumrukcu G, Kutluhan MA, Karaman MI. Protective effect of udenafil against ischemia reperfusion injury due to testicular torsion/detorsion in rat model. Eurasian J Med. 2020;52(2):115–19. doi:10.5152/eurasianjmed.2020.19229.
   PubMed Web of Science ®Google Scholar
• Corona G, Rastrelli G, Burri A, Jannini EA, Maggi M. The safety and efficacy of Avanafil, a new 2nd generation PDE5i: comprehensive review and meta-analysis. Expert Opin Drug Saf. 2016;15(2):237–47. doi:10.1517/14740338.2016.1130126.
   PubMed Web of Science ®Google Scholar
• Sakamoto T, Koga Y, Hikota M, Matsuki K, Murakami M, Kikkawa K, Fujishige K, Kotera J, Omori K, Morimoto H, et al. The discovery of avanafil for the treatment of erectile dysfunction: a novel pyrimidine-5-carboxamide derivative as a potent and highly selective phosphodiesterase 5 inhibitor. Bioorg Med Chem Lett. 2014;24(23):5460–65. doi:10.1016/j.bmcl.2014.10.008.
   PubMed Web of Science ®Google Scholar
• Kedia G, Uckert S, Assadi-Pour F, Kuczyk M, Albrecht K. Avanafil for the treatment of erectile dysfunction: initial data and clinical key properties. Ther Adv Urol. 2013;5(1):35–41. doi:10.1177/1756287212466282.
   PubMedGoogle Scholar
• Hong P, Gu R-N, Li F-X, Xiong X-X, Liang W-B, You Z-J, Zhang H-F. NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes. J Neuroinflammation. 2019;16(1):121. doi:10.1186/s12974-019-1498-0.
   PubMed Web of Science ®Google Scholar
• Zhou W, Chen C, Chen Z, Liu L, Jiang J, Wu Z, Zhao M, Chen Y. NLRP3: a novel mediator in cardiovascular disease. J Immunol Res. 2018;2018:1–8. doi:10.1155/2018/5702103.
   Web of Science ®Google Scholar
• Huyut Z, Bakan N, Akbay Hİ, Yıldırım S, Şekeroğlu MR. Zaprinast and avanafil increase the vascular endothelial growth factor, vitamin D3, bone morphogenic proteins 4 and 7 levels in the kidney tissue of male rats applied the glucocorticoid. Arch Physiol Biochem. 2020;128(5):1290–1296. doi:10.1080/13813455.2020.1767149.
   PubMed Web of Science ®Google Scholar
• Huyut Z, Bakan N, Yıldırım S, Akbay Hİ, Huyut MT, Ahlatçı A, Uçar B. Can zaprinast and avanafil induce the levels of angiogenesis, bone morphogenic protein 2, 4 and 7 in kidney of ovariectomised rats? Arch Physiol Biochem. 2020;128(4):945–950. doi:10.1080/13813455.2020.1740743.
   PubMed Web of Science ®Google Scholar
• Roundtable STAI. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke. 1999;30(12):2752–58.
   PubMed Web of Science ®Google Scholar
• McBride DW, Zhang JH. Precision stroke animal models: the permanent MCAO model should be the primary model, not transient MCAO. Transl Stroke Res. 2017;8(5):397–404. doi:10.1007/s12975-017-0554-2.
   Web of Science ®Google Scholar
• Hacke W. ATLANTIS Trials investigators; ECASS trials investigators; NINDS rt-PA study group investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363:768–74.
   PubMed Web of Science ®Google Scholar
• Helms G, Garea-Rodriguez E, Schlumbohm C, König J, Dechent P, Fuchs E, Wilke M. Structural and quantitative neuroimaging of the common marmoset monkey using a clinical MRI system. J Neurosci Methods. 2013;215(1):121–31. doi:10.1016/j.jneumeth.2013.02.011.
   PubMed Web of Science ®Google Scholar
• Sarshoori JR, Asadi MH, Mohammadi MT. Neuroprotective effects of crocin on the histopathological alterations following brain ischemia-reperfusion injury in rat. Iran J Basic Med Sci. 2014;17(11):895.
   PubMed Web of Science ®Google Scholar
• Lakics V, Karran EH, Boess FG. Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues. Neuropharmacology. 2010;59(6):367–74. doi:10.1016/j.neuropharm.2010.05.004.
   PubMed Web of Science ®Google Scholar
• Gur S, Kadowitz PJ, Serefoglu EC, Hellstrom WJ. PDE5 inhibitor treatment options for urologic and non-urologic indications: 2012 update. Curr Pharm Des. 2012;18(34):5590–606. doi:10.2174/138161212803307554.
   PubMed Web of Science ®Google Scholar
• Liebenberg N, Harvey BH, Brand L, Wegener G, Brink CB. Chronic treatment with the phosphodiesterase type 5 inhibitors sildenafil and tadalafil display anxiolytic effects in flinders sensitive line rats. Metab Brain Dis. 2012;27(3):337–40. doi:10.1007/s11011-012-9284-z.
   PubMed Web of Science ®Google Scholar
• García-Osta A, Cuadrado-Tejedor M, García-Barroso C, Oyarzábal J, Franco R. Phosphodiesterases as therapeutic targets for Alzheimer’s disease. ACS Chem Neurosci. 2012;3(11):832–44. doi:10.1021/cn3000907.
   PubMed Web of Science ®Google Scholar
• Kammoun AK, Khedr A, Ahmed OAA. LC-MS/MS determination of avanafil and its metabolites in rat plasma and brain: pharmacokinetic study after oral administration and transdermal film application. RSC Adv. 2020;10(16):9407–13. doi:10.1039/D0RA00569J.
   PubMed Web of Science ®Google Scholar
• Potter LR. Guanylyl cyclase structure, function and regulation. Cell Signal. 2011;23(12):1921–26. doi:10.1016/j.cellsig.2011.09.001.
   PubMed Web of Science ®Google Scholar
• Maki T, Okamoto Y, Carare RO, Hase Y, Hattori Y, Hawkes CA, Saito S, Yamamoto Y, Terasaki Y, Ishibashi‐Ueda H, et al. Phosphodiesterase III inhibitor promotes drainage of cerebrovascular β-amyloid. Ann Clin Transl Neurol. 2014;1(8):519–33. doi:10.1002/acn3.79.
   PubMed Web of Science ®Google Scholar
• Ribaudo G, Ongaro A, Zagotto G, Memo M, Gianoncelli A. Therapeutic potential of phosphodiesterase inhibitors against neurodegeneration: the perspective of the medicinal chemist. ACS Chem Neurosci. 2020;11(12):1726–39. doi:10.1021/acschemneuro.0c00244.
   PubMed Web of Science ®Google Scholar
• Elhwuegi AS. The wonders of phosphodiesterase-5 inhibitors: a majestic history. Ann Med Health Sci Res. 2016;6(3):139–45. doi:10.4103/2141-9248.183943.
   PubMedGoogle Scholar
• Džoljić E, Grbatinić I, Kostić V. Why is nitric oxide important for our brain? Funct Neurol. 2015;30(3):159–63. doi:10.11138/FNeur/2015.30.3.159.
   PubMed Web of Science ®Google Scholar
• Nagendran J, Archer SL, Soliman D, Gurtu V, Haromy A Aubin CS, Webster L, Rebeyka IM, Ross DB. Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility, et al. Circulation. 2007;116(3): 238–48.
   PubMed Web of Science ®Google Scholar
• Salloum FN, Takenoshita Y, Ockaili RA, Daoud VP, Chou E, Yoshida K-I, Kukreja RC. Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial KATP channels when administered at reperfusion following ischemia in rabbits. J Mol Cell Cardiol. 2007;42(2):453–58. doi:10.1016/j.yjmcc.2006.10.015.
   PubMed Web of Science ®Google Scholar
• Moore HM, Drucker NA, Hosfield BD, Shelley WC, Markel TA. Sildenafil as a rescue agent following intestinal ischemia and reperfusion injury. J Surg Res. 2020;246:512–18. doi:10.1016/j.jss.2019.09.037.
   PubMed Web of Science ®Google Scholar
• Zahran MH, Barakat N, Khater S, Awadalla A, Mosbah A, Nabeeh A, Hussein AM, Shokeir AA. Renoprotective effect of local sildenafil administration in renal ischaemia–reperfusion injury: a randomised controlled canine study. Arab J Urol. 2019;17(2):150–59. doi:10.1080/2090598X.2019.1600995.
   PubMed Web of Science ®Google Scholar
• Cadirci E, Halici Z, Odabasoglu F, Albayrak A, Karakus E, Unal D, Atalay F, Ferah I, Unal B. Sildenafil treatment attenuates lung and kidney injury due to overproduction of oxidant activity in a rat model of sepsis: a biochemical and histopathological study. Clin Exp Immunol. 2011;166(3):374–84. doi:10.1111/j.1365-2249.2011.04483.x.
   PubMed Web of Science ®Google Scholar
• Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Ischemia/reperfusion. Compr Physiol. 2016;7(1):113–70.
   PubMed Web of Science ®Google Scholar
• Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol. 2012;298:229–317.
   PubMed Web of Science ®Google Scholar
• Wu MY, Yiang GT, Liao WT, Tsai APY, Cheng YL, Cheng PW, Li C-Y, Li C-J. Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem. 2018;46(4):1650–67. doi:10.1159/000489241.
   PubMedGoogle Scholar
• Yu H, Kalogeris T, Korthuis RJ. Reactive species-induced microvascular dysfunction in ischemia/reperfusion. Free Radic Biol Med. 2019;135:182–97. doi:10.1016/j.freeradbiomed.2019.02.031.
   PubMed Web of Science ®Google Scholar
• El-Agamy DS, Almaramhy HH, Ahmed N, Bojan B, Alrohily WD, Elkablawy MA. Anti-inflammatory effects of vardenafil against cholestatic liver damage in mice: a mechanistic study. Cell Physiol Biochem. 2018;47(2):523–34. doi:10.1159/000489986.
   PubMedGoogle Scholar
• Fusco R, Siracusa R, Genovese T, Cuzzocrea S, Di Paola R. Focus on the role of NLRP3 inflammasome in diseases. Int J Mol Sci. 2020;21(12):4223. doi:10.3390/ijms21124223.
   PubMed Web of Science ®Google Scholar
• Burne MJ, Elghandour A, Haq M, Saba SR, Norman J, Condon T, Bennett F, Rabb H. IL-1 and TNF independent pathways mediate ICAM-1/VCAM-1 up-regulation in ischemia reperfusion injury. J Leukoc Biol. 2001;70(2):192–98. doi:10.1189/jlb.70.2.192.
   PubMed Web of Science ®Google Scholar
• Chan AH, Schroder K. Inflammasome signaling and regulation of interleukin-1 family cytokines. J Exp Med. 2020;217(1). doi:10.1084/jem.20190314.
   Web of Science ®Google Scholar
• Franke M, Bieber M, Kraft P, Weber ANR, Stoll G, Schuhmann MK. The NLRP3 inflammasome drives inflammation in ischemia/reperfusion injury after transient middle cerebral artery occlusion in mice. Brain Behav Immun. 2021;92:223–33. doi:10.1016/j.bbi.2020.12.009.
   PubMed Web of Science ®Google Scholar
• He Q, Li Z, Wang Y, Hou Y, Li L, Zhao J. Resveratrol alleviates cerebral ischemia/reperfusion injury in rats by inhibiting NLRP3 inflammasome activation through Sirt1-dependent autophagy induction. Int Immunopharmacol. 2017;50:208–15. doi:10.1016/j.intimp.2017.06.029.
   PubMed Web of Science ®Google Scholar
• Abais JM, Xia M, Zhang Y, Boini KM, P-L L. Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector? Antioxid Redox Signal. 2015;22(13):1111–29. doi:10.1089/ars.2014.5994.
   PubMed Web of Science ®Google Scholar
• Toldo S, Mauro AG, Cutter Z, Abbate A. Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2018;315(6):H1553–h68. doi:10.1152/ajpheart.00158.2018.
   PubMed Web of Science ®Google Scholar
• Liu Z, Qu M, Yu L, Song P, Chang Y. Artesunate inhibits renal ischemia-reperfusion-mediated remote lung inflammation through attenuating ROS-Induced activation of NLRP3 inflammasome. Inflammation. 2018;41(4):1546–56. doi:10.1007/s10753-018-0801-z.
   PubMed Web of Science ®Google Scholar
• Zhou T, Xiang DK, Li SN, Yang LH, Gao LF, Feng C. MicroRNA-495 ameliorates cardiac microvascular endothelial cell injury and inflammatory reaction by suppressing the NLRP3 inflammasome signaling pathway. Cell Physiol Biochem. 2018;49(2):798–815. doi:10.1159/000493042.
   PubMedGoogle Scholar
• Iyer SS, He Q, Janczy JR, Elliott EI, Zhong Z, Olivier AK, Sadler J, Knepper-Adrian V, Han R, Qiao L, et al. Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity. 2013;39(2):311–23. doi:10.1016/j.immuni.2013.08.001.
   PubMed Web of Science ®Google Scholar
• Fann DY, Lee SY, Manzanero S, Tang SC, Gelderblom M, Chunduri P, Bernreuther C, Glatzel M, Cheng Y-L, Thundyil J, et al. Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke. Cell Death Disease. 2013;4(9):e790. doi:10.1038/cddis.2013.326.
   PubMedGoogle Scholar
• Martín-Sánchez F, Diamond C, Zeitler M, Gomez AI, Baroja-Mazo A, Bagnall J, Spiller D, White M, Daniels MJD, Mortellaro A, et al. Inflammasome-dependent IL-1β release depends upon membrane permeabilisation. Cell Death Differ. 2016;23(7):1219–31. doi:10.1038/cdd.2015.176.
   PubMed Web of Science ®Google Scholar
• de Santana Nunes AK, Rapôso C, de Almeida Luna RL, da Cruz-Höfling MA, Peixoto CA. Sildenafil (Viagra®) down regulates cytokines and prevents demyelination in a cuprizone-induced MS mouse model. Cytokine. 2012;60(2):540–51. doi:10.1016/j.cyto.2012.06.011.
   PubMed Web of Science ®Google Scholar
• Luna R, Nunes A, Oliveira A, Araujo S, Lemos A, Rocha S, Croy BA, Peixoto CA. Sildenafil (Viagra®) blocks inflammatory injury in LPS-induced mouse abortion: a potential prophylactic treatment against acute pregnancy loss? Placenta. 2015;36(10):1122–29. doi:10.1016/j.placenta.2015.07.133.
   PubMed Web of Science ®Google Scholar